Direct to Consumer Genetic Testing Market, By Application (Health Testing, Carrier Testing (Diagnosis screening), Nutrigenetic Testing, Ancestry, Relationship Testing, Talent Testing, and Matchmaking), By Type of Sample (Saliva, Blood), By Region - Global Analysis Forecast Till 2030

The Direct to Consumer genetic testing Market is valued at 1.8 billion in 2021 and is expected to grow at a 17.1% CAGR from 2022 to 2030.

The rising prevalence of rare genetic diseases is expected to drive market expansion. Rising demand for personalized genetic services, as well as increased public awareness around the world, are expected to aid market growth.

The DTC genetic testing industry is fragmented, with a few dominant players and other small start-up companies offering superior Amidst at lower costs, which will address affordability issues and positively impact market growth. The COVID-19 pandemic boosted the direct-to-consumer genetic testing market. In the midst of the pandemic, techno-personalized cement has paved the way for new business opportunities in direct-to-consumer genetic testing. The rise in the prevalence of chronic diseases, as well have the introduction of personalized testing kits for niche therapeutic areas are assisting in the rapid expansion of direct-to-consumer genetic testing. Such service adaptation and change have increased the demand for such kits. The availability of these kits on online platform services will also positively impact market statistics.

Market Dynamics:

Drivers:

Increasing customer demand for transparency in test performance drives industry growth

Customers seeking information on their health status, ancestry, disease risk, and their body's expected response to specific medicines based on their genotypes may benefit from direct-to-consumer testing, an intriguing addition to the traditional healthcare system. According to the traditional concept of laboratory analysis in a hospital, the client must first decide whether to see a doctor.

Consumers should brace themselves for a healthcare reform system that provides greater convenience and thorough clinical findings without time consuming treatments. Furthermore, the number of direct to consumer tests being conducted is increasing, and DTC testing has been marketed for various applications. Common types of samples include urine, cheek swabs, blood spots, saliva or spit, hair, and blood.

Restraints

The direct-to-consumer genetic testing market forecast may be hampered by high prices connected with DTC genetic testing services. In order to launch high-end DTC testing, many manufacturers are concentrating on product improvements and integrating next-generation technology, which raises the price of the device. Because of economic difficulties, the demand for genetic services in developing and impoverished areas may be hampered.

Key players:

• 23andMe, Inc

• Ambry Genetics Corp.

• Ancestry.com LLC

• Any Lab Test Now, Inc.

• Color Genomics, Inc

• Counsyl, Inc.

• DanteLabs Inc.

• Direct Laboratory Services, LLC

• Eastern Biotech & Life Sciences

• EasyDNA

• EverlyWell, Inc., 

• Full Genomes Corporation, Inc.

• Gene by Gene, Ltd.

• Genecodebook Oy

• Genesis Healthcare Co.

• Genetrainer

• GHC Genetics UK

• HealthCheckUSA

• Home Access Health Corporation

• International Biosciences

• Laboratory Corporation of America Holdings

• LetsGetChecked, Inc.

Market Segmentation:

Direct to Consumer Genetic Testing Market, By Application

• Health Testing

  • Carrier Testing (Diagnosis screening)

  • Nutrigenetic Testing

• Ancestry

• Relationship Testing

• Talent Testing

• Matchmaking

• Others

Direct to Consumer Genetic Testing Market, By Type of Sample

• Saliva

• Blood

• Others

Direct to Consumer Genetic Testing Market, By Region

• North America

• Latin America

• Europe

• Asia Pacific

• Middle East & Africa

Regional Analysis

With direct-to-consumer tests performed globally during the projection period, North America is expected to have a significant market share. North America dominated the global DTC testing industry due to the importance of early detection for improved treatment outcomes and a higher standard of consumer knowledge about illnesses. Due to an increase in the incidence of several lifestyle-related and infectious disorders, such as obesity, cancer, diabetes, and STDs, the need for direct-to-consumer lab testing with earlier detection is expected to increase in North America during the projected timeframe.

In terms of revenue share in 2021, the Asia Pacific region came in second. Over the past five years, China's DTC genetic testing market has also grown exponentially. According to a recent study, there would be XX% million DTC-GT users on the Chinese mainland by 2020. Leading Chinese DTC-GT vendors like WeGene and 23mofang presently provide consumers with a range of DTC-GT products, which may be obtained by phone without needing a medical administrator. Due to the nature of the vast genetic data, DTC-GT is a viable tool for enhancing the health of segments of the population who are predisposed to specific diseases and disorders.

Scope of the Report:

User

Tab Content